Cubist Pharmaceuticals, Inc.CBST -0.11% today announced that Charles Laranjeira has joined the company as Senior Vice President of Technical Operations. Mr. Laranjeira oversees all facets of Cubist's technical operations, including global manufacturing, quality, supply chain, and distribution. He reports to Robert Perez, Cubist's Chief Operating Officer.Mr. Laranjeira comes to Cubist from Bristol-Myers Squibb (BMS) where he developed considerable expertise in global industrial operations management, including international pharmaceutical manufacturing. Most recently, he served as Vice President of Latin America, Asia Pacific & Japan, where he was responsible for regional operations management and product supply management to all markets within those regions. Prior to that position, he was Vice President of Asia Pacific and Japan, based in Singapore, and Vice President & General Manager, based in Puerto Rico. Mr. Laranjeira's earlier positions with BMS include various roles of increasing responsibilities in technical operations, manufacturing, and industrial engineering in Spain, Australia, and the United States."We are delighted to welcome Chuck Laranjeira to Cubist during this transformational year for the company," said Mr. Perez. "Chuck combines broad and diverse international experience with an outstanding track record of building and leading successful global teams. I am confident that his vast experience and strong leadership will be instrumental as Cubist expands to become a global acute care leader in the years ahead."
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment